CIK 0001818838 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in E9 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-02 | 4 | OWNERSHIP DOCUMENT | 2026-09-30 |
| 2026-09-25 | 4 | OWNERSHIP DOCUMENT | 2026-09-23 |
| 2026-09-25 | 6-K | FORM 6-K | 2026-09-25 |
| 2026-09-22 | 6-K | FORM 6-K | 2026-09-22 |
| 2026-09-17 | 4 | OWNERSHIP DOCUMENT | 2026-09-16 |
| 2026-09-10 | 6-K | FORM 6-K | 2026-09-10 |
| 2026-09-09 | 6-K | FORM 6-K | 2026-09-09 |
| 2026-08-20 | 144/A | 144/A | |
| 2026-08-19 | 144 | 144 | |
| 2026-08-18 | 4 | OWNERSHIP DOCUMENT | 2026-08-14 |
| 2026-08-17 | 4 | OWNERSHIP DOCUMENT | 2026-08-13 |
| 2026-08-17 | 4 | OWNERSHIP DOCUMENT | 2026-08-13 |
| 2026-08-17 | 4 | OWNERSHIP DOCUMENT | 2026-08-13 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | 4 | PRIMARY DOCUMENT | 2026-08-13 |
| 2026-08-12 | 6-K | 6-K | 2026-06-30 |
| 2026-08-06 | 4 | OWNERSHIP DOCUMENT | 2026-08-06 |
| 2026-07-06 | 6-K | FORM 6-K | 2026-07-06 |
| 2026-06-08 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-07 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-04-17 | 6-K | FORM 6-K | 2026-04-17 |
| 2026-04-02 | 424B5 | 424B5 | |
| 2026-04-02 | 6-K | FORM 6-K | 2026-04-02 |
| 2026-04-02 | 424B5 | 424B5 |
Forms on file (last 1,000): 6-K 68, CORRESP 16, SCHEDULE 13G/A 12, 3 10, 4 9, UPLOAD 9, SC 13G 7, 20-F 6. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ADAG (0.002 USD), /gw/filings/filings?ticker=ADAG&form=8-K, /gw/filings/facts?ticker=ADAG&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange